Profile Image

Professor Chris Dayas

Assistant Dean Research

School of Biomedical Sciences and Pharmacy (Anatomy)

From neurons to networks to behaviour

A contemporary contributor to understandings of the central nervous system, Associate Professor Chris Dayas is proving – and, at times, disproving – ideas about the brain’s structure and its influence on motivation and emotion.

Mapping the brain is akin to playing Connect the Dots – without the helpful alphabetical and numerical hints. Indeed, in the neuroscience version, the large and obvious points are replaced by much smaller, microscopic cellular arrangements numbered in the billions, and the lines, though similarly serving to join each salient feature, represent the technical and nuanced instead of the sublimely superficial. It’s an almost incomprehensible maze of pathways telling us how and what and why and when we think and act, as intricate and delicate as the organ itself. Associate Professor Chris Dayas, an expert in this interdisciplinary field, is meeting this challenge head-on.

“My research focuses on the brain’s motivation and emotion centres,” he elaborates.

“While they are separate regions, they are highly interconnected and talk to each other.”

I’m interested in exploring these connections, right down to the molecular and cellular changes that occur.

Originally planning to pursue a childhood interest in marine biology, Chris credits several “inspiring” mentors for his rewarding and fruitful switch to neuroscience. Singling out high school teacher and marine biologist Ted Brambleby and university Professors Trevor Day and Janet Keast, the avid surfer and ocean enthusiast speaks of successful crossovers into psychiatry and public health as well.

“I’m passionate about finding better outcomes for pathologies of motivation and emotion, such as drug addiction and depression,” he asserts.

Before we can do this we need to gain a better understanding of the neuroanatomical and neurochemical interactions between key components of brain circuitry that are thought to be responsible for provoking relapse to these conditions.”

“Although much progress has been made in identifying individual brain regions that elicit reward-seeking behaviour, there are presently very few effective therapies available to treat pathological reward seeking – a core symptom of addiction and obesity – as well as depression, where the opposite occurs, you see low motivation and reward seeking.”

Getting specific

Chris’ research career began in 1997 when he undertook a PhD at the University of Queensland. Chiefly concentrating on the emotional side of the brain, the four-year probe sought to investigate how the brain responds to different types of stress.

“At the time, there was general consensus among scholars that the brain responds to all types of stress the same way,” he recalls.

“I identified, however, that psychological stresses, or ‘perceived threats’ important for the onset of neuropsychiatric conditions such as depression, activated a different part of the amygdala compared to physiological stresses, such as hypoxia and haemorrhage.”

“I found that psychological and physiological stress elicits distinct activity ‘footprints’ within this subcortical structure as well as sub-populations of catecholamine cells, like noradrenaline and dopamine cells within the brainstem.”

A stubborn problem

Awarded a prestigious CJ Martin Fellowship from the National Health and Medical Research Council (NHMRC) after receiving his award in 2001, Chris relocated to the United States to undertake postdoctoral training at The Scripps Research Institute. Principally focusing on alcohol addiction, the 2002-2006 stint in California’s sunny and surf capital ended up “intellectually fusing” two of the Brisbane native’s primary interests.

“The parts of the brain that deal with stress connect to the hypothalamus, which reacts to drug abuse,” he explains.

“I endeavoured to bring these two interests together.”

Aspiring to help build a solid knowledge base around the neural pathways that control reinstatement of alcohol relapse, Chris published his overseas findings in the high profile journals Biological Psychiatry and the Journal of Neuroscience.

“We showed that cells in the hypothalamus, which people used to think were important solely in food-seeking, are involved in drug addiction too,” he reveals.

“Hypothalamic peptide systems, better known for their role in feeding behaviour, may therefore be significant neurotransmitters in the brain circuitry that trigger alcohol-seeking behaviour.”

“We’re still studying them very closely.”

Creative and scientific in equal measure, Chris employed a number of different methods to shed light on these connections.

“We used antibodies to bind to the cells and immunofluorescence to look at their structure,” he shares.

“Markers of activity were also established to help analyse how the cells changed over time.”

“I was lucky enough to work with Associate Professor Brett Graham, an electrophysiologist, and Dr Doug Smith, a molecular biologist, as well.”

Pinpoint accuracy

Chris moved to the University of Newcastle in 2007 to set up his own laboratory in the Discipline of Anatomy, School of Biomedical Sciences and Pharmacy where he continues to examine the role of hypothalamic peptides in driving drug-seeking and relapse-like behaviour.

“I received a generous grant from the NHMRC to commence this work,” he states.

“We’re applying new, cutting-edge techniques to see how cellular connections alter following drug abuse or chronic stress.”

Referring particularly to optogenetics, which involves the use of light to control cells in living tissue, Chris believes these new “genetic tricks” will quickly advance our understanding of the brain, and hopefully identify new treatments.

“My group is using this process of inserting light-activatable proteins from algae into various types of brain cells,” he discloses.

“This will allow us to experimentally ‘shine a light’ on connections between different parts of the brain.”

“Glencore recently awarded us a philanthropic grant to buy a specialised ‘optogenetics’ microscope specifically designed for such a purpose.”

“It’s in its early days but we’re getting some fascinating results.”

Related links

Chris Dayas

From neurons to networks to behaviour

A contemporary contributor to understandings of the central nervous system, Associate Professor Chris Dayas is proving – and, at times, disproving – ideas about

Read more

Career Summary

Biography

I completed my PhD at the University of Queensland, Brisbane, Australia in 2000. The focus of this work was to identify parts of the brain that controlled neuroendocrine responses to different forms of stress. This work showed that different categories of stress - psychological or physiological (e.g. infection) - elicit distinct cellular activity "footprints" within the amygdala and sub-populations of catecholamine cells within the brainstem. This finding was because the consensus at the time was that these brain regions responded homogenously to stress irrespective of the 'category' or nature of the stimulus. At the end of my PhD I was awarded a CJ Martin fellowship from the NHMRC that allowed me to travel to the United States to undertake post-doctoral training at The Scripps Research Institute in California, San Diego.

My post-doctoral research at The Scripps Research Institute contributed to the understanding of the neural pathways that control reinstatement of alcohol relapse. In articles published in the journal Biological Psychiatry and Journal of Neuroscience, I showed that the pattern of neural activity elicited by stimuli conditioned to predict the availability of alcohol, a factor linked to increased relapse risk in humans, is similar to the patterns produced by stimuli paired with the availability of other commonly abused drugs such as cocaine or nicotine. Additionally, we demonstrated how existing neuropharmacological treatments for alcoholism such as naltrexone, or newer agents that show promise in the treatment of addiction such as agonists for group II/III metabotropic glutamate (mGlu2/3) receptors, also modulate these patterns. We also showed that mGlu2/3 receptor agonists, which appear to have an anxiolytic profile, are effective in suppressing reinstatement (or relapse) elicited by stress - an important trigger for relapse in humans.
At Scripps I also demonstrated that hypothalamic peptide systems, better known for their role in feeding behaviour, may be important neurotransmitters in the brain circuitry that trigger alcohol seeking behaviour.

After returning to Australia, I established my own laboratory in the Discipline of Anatomy, School of Biomedical Sciences and Pharmacy, University of Newcastle to investigate the role of these hypothalamic peptides in driving drug-seeking and relapse-like behaviour. I received an NHMRC grant in to commence this work. My laboratory therefore focuses on the brain pathways that are involved in addiction and stress.

Research Expertise
Relapse to drug taking is considered the most significant obstacle to the successful treatment of addiction. Although much progress has been made in identifying individual brain regions that elicit drug-seeking behaviour and subsequently relapse, there are presently very few effectively pharmaceutical or indeed behavioural therapy strategies available to treat this disease. My research interests concern the following key issues: 1.Understanding the neuroanatomical and pharmacological interactions between key components of brain circuitry thought to be responsible for provoking drug relapse. 2.Determining the role of the neuropeptides (orexin/hypocretin and CART) recently found to be powerful modulators of drug-seeking and relapse. 3.Elucidating the cellular and molecular neuroadaptations that promotes long-term relapse vulnerability. 4.Determining the neurobiological basis for why some individuals become addicted and show greater vulnerability to drug relapse than others. 

Collaborations
Relapse to drug taking is considered the most significant obstacle to the successful treatment of addiction. Although much progress has been made in identifying individual brain regions that elicit drug-seeking behaviour and subsequently relapse, there are presently very few effectively pharmaceutical or indeed behavioural therapy strategies available to treat this disease. My research interests concern the following key issues: 1. Understanding the neuroanatomical and pharmacological interactions between key components of brain circuitry thought to be responsible for provoking drug relapse. 2. Determining the role of the neuropeptides (orexin/hypocretin and CART) recently found to be powerful modulators of drug-seeking and relapse. 3. Elucidating the cellular and molecular neuroadaptations that promotes long-term relapse vulnerability. 4. Determining the neurobiological basis for why some individuals become addicted and show greater vulnerability to drug relapse than others.

Qualifications

  • PhD, University of Queensland
  • Bachelor of Science (Honours), University of Queensland

Keywords

  • Neurosciences

Fields of Research

Code Description Percentage
320999 Neurosciences not elsewhere classified 100

Professional Experience

UON Appointment

Title Organisation / Department
Professor University of Newcastle
School of Biomedical Sciences and Pharmacy
Australia

Academic appointment

Dates Title Organisation / Department
1/11/2006 - 1/12/2008 CJ Martin Biomedical Fellowships (Overseas)

NHMRC - Early Career Fellowships (Formerly Postdoctoral Training Fellowships)

National Health & Medical Research Council

Membership

Dates Title Organisation / Department
Member - Society for Neuroscience Society for Neuroscience
Australia
Member - Australian Neuroscience Society Australian Neuroscience Society (ANS)
Australia
Member - Research Society on Alcoholism Research Society on Alcoholism
Australia

Invitations

Participant

Year Title / Rationale
2004 " Invited speaker at the Research Society on Alcoholism Meeting in Vancouver, Canada, 2004
Organisation: Research Society on Alcholism
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.


Chapter (3 outputs)

Year Citation Altmetrics Link
2021 Gordon GR, Dayas C, Bains J, 'Astrocyte Magnocellular Neuron Interactions in Hypothalamic Memory', Glial-Neuronal Signaling in Neuroendocrine Systems, Springer Nature, Cham, Switzerland 81-103 (2021) [B1]
2017 James MH, Campbell EJ, Dayas CV, 'Role of the Orexin/Hypocretin system in stress-related psychiatric disorders', Behavioral Neuroscience of Orexin/Hypocretin, Springer, New York 197-219 (2017) [B1]
DOI 10.1007/7854_2016_56
Citations Scopus - 86
Co-authors Erin J Campbell
2015 Caille S, Baker AL, Todd J, Turner A, Dayas CV, 'Smoking and mental health problems', The Tobacco Epidemic, S. Karger AG, Basel, Switzerland 199-209 (2015) [B1]
DOI 10.1159/000369483
Co-authors Amanda Baker, Juanita Todd

Journal article (63 outputs)

Year Citation Altmetrics Link
2024 Mitchell CS, Campbell EJ, Fisher SD, Stanton LM, Burton NJ, Pearl AJ, et al., 'Optogenetic recruitment of hypothalamic corticotrophin-releasing-hormone (CRH) neurons reduces motivational drive.', Transl Psychiatry, 14 8 (2024) [C1]
DOI 10.1038/s41398-023-02710-0
Co-authors Erin J Campbell, Brett Graham, Lizzie Manning
2024 Duchatel RJ, Jackson ER, Parackal SG, Kiltschewskij D, Findlay IJ, Mannan A, et al., 'PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma.', J Clin Invest, 134 (2024) [C1]
DOI 10.1172/JCI170329
Citations Scopus - 2
Co-authors Lizzie Manning, Matt Dun, Ryan Duchatel, Brett Nixon, Heather Murray, Murray Cairns, Susan Hua, David Skerrett-Byrne, Muhammad Jamaluddin
2023 G Anversa R, Campbell EJ, Walker LC, S Ch'ng S, Muthmainah M, S Kremer F, et al., 'A paraventricular thalamus to insular cortex glutamatergic projection gates "emotional" stress-induced binge eating in females.', Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 48 1931-1940 (2023) [C1]
DOI 10.1038/s41386-023-01665-6
Co-authors Erin J Campbell
2023 Greco L, 'Exploring opportunities for drug repurposing and precision medicine in cannabis use disorder using genetics', Addiction Biology, (2023) [C1]
DOI 10.1111/adb.13313
Citations Scopus - 1
Co-authors Laura Greco, William Reay Uon, Murray Cairns
2022 Gradwell MA, Boyle KA, Browne TJ, Bell AM, Leonardo J, Reyes FSP, et al., 'Diversity of inhibitory and excitatory parvalbumin interneuron circuits in the dorsal horn', PAIN, 163 E432-E452 (2022) [C1]
DOI 10.1097/j.pain.0000000000002422
Citations Scopus - 15Web of Science - 5
Co-authors Robert Callister, Tyler Browne, Brett Graham
2022 Gradwell MA, Smith KM, Dayas CV, Smith DW, Hughes DI, Callister RJ, Graham BA, 'Altered Intrinsic Properties and Inhibitory Connectivity in Aged Parvalbumin-Expressing Dorsal Horn Neurons', FRONTIERS IN NEURAL CIRCUITS, 16 (2022) [C1]
DOI 10.3389/fncir.2022.834173
Citations Scopus - 1
Co-authors Brett Graham, Douglas Smith, Robert Callister
2022 Reichenbach A, Clarke RE, Stark R, Lockie SH, Mequinion M, Dempsey H, et al., 'Metabolic sensing in AgRP neurons integrates homeostatic state with dopamine signalling in the striatum.', Elife, 11 (2022) [C1]
DOI 10.7554/eLife.72668
Citations Scopus - 24Web of Science - 8
2022 Brown RM, Dayas CV, James MH, Smith RJ, 'New directions in modelling dysregulated reward seeking for food and drugs', Neuroscience and Biobehavioral Reviews, 132 1037-1048 (2022) [C1]

Behavioral models are central to behavioral neuroscience. To study the neural mechanisms of maladaptive behaviors (including binge eating and drug addiction), it is essential to d... [more]

Behavioral models are central to behavioral neuroscience. To study the neural mechanisms of maladaptive behaviors (including binge eating and drug addiction), it is essential to develop and utilize appropriate animal models that specifically focus on dysregulated reward seeking. Both food and cocaine are typically consumed in a regulated manner by rodents, motivated by reward and homeostatic mechanisms. However, both food and cocaine seeking can become dysregulated, resulting in binge-like consumption and compulsive patterns of intake. The speakers in this symposium for the 2021 International Behavioral Neuroscience Meeting utilize behavioral models of dysregulated reward-seeking to investigate the neural mechanisms of binge-like consumption, enhanced cue-driven reward seeking, excessive motivation, and continued use despite negative consequences. In this review, we outline examples of maladaptive patterns of intake and explore recent animal models that drive behavior to become dysregulated, including stress exposure and intermittent access to rewards. Lastly, we explore select behavioral and neural mechanisms underlying dysregulated reward-seeking for both food and drugs.

DOI 10.1016/j.neubiorev.2021.10.043
Citations Scopus - 14Web of Science - 5
2022 Greco LA, Reay WR, Dayas C, Cairns MJ, 'Pairwise genetic meta-analyses between schizophrenia and substance dependence phenotypes reveals novel association signals with pharmacological significance', TRANSLATIONAL PSYCHIATRY, 12 (2022) [C1]
DOI 10.1038/s41398-022-02186-4
Citations Scopus - 3Web of Science - 1
Co-authors Murray Cairns, William Reay Uon, Laura Greco
2021 Whatnall M, Skinner J, Verdejo-Garcia A, Carter A, Brown RM, Andrews ZB, et al., 'Symptoms of Addictive Eating: What Do Different Health Professions Think?', BEHAVIORAL SCIENCES, 11 (2021) [C1]
DOI 10.3390/bs11050060
Citations Scopus - 1Web of Science - 1
Co-authors Megan Whatnall, Tracy Burrows, Janelle Skinner
2021 Browne TJ, Smith KM, Gradwell MA, Iredale JA, Dayas CV, Callister RJ, et al., 'Spinoparabrachial projection neurons form distinct classes in the mouse dorsal horn', PAIN, 162 1977-1994 (2021) [C1]
DOI 10.1097/j.pain.0000000000002194
Citations Scopus - 13Web of Science - 7
Co-authors Jacqueline Iredale, Brett Graham, Tyler Browne, Robert Callister
2020 Burrows T, Verdejo-Garcia A, Carter A, Brown RM, Andrews ZB, Dayas CV, et al., 'Health professionals and health professional trainees views on addictive eating behaviours: A cross-sectional survey', Nutrients, 12 1-15 (2020) [C1]
DOI 10.3390/nu12092860
Citations Scopus - 9Web of Science - 5
Co-authors Tracy Burrows, Megan Whatnall
2020 Skinner JA, Garg ML, Dayas CV, Burrows TL, 'Using participant ratings to construct food image paradigms for use in the Australian population A pilot study', Food Quality and Preference, 82 (2020) [C1]

In human research, images of food are often used as cues in place of real foods. To elicit anticipatory responses in targeted populations (e.g. prompting changes in metabolic horm... [more]

In human research, images of food are often used as cues in place of real foods. To elicit anticipatory responses in targeted populations (e.g. prompting changes in metabolic hormones, invoking food cravings), cultural differences and population norms with regard to food preferences need to be considered. This pilot study aimed to construct two image paradigms (healthy vs. hyperpalatable foods) for experimental use within the Australian population. A dataset of 200 images (from the licenced database Food-pics and internet sources), representative of healthy and hyperpalatable foods commonly consumed in Australia, was compiled by research dietitians. Ten male and female adults volunteered to view the images. Participants categorised each image as either healthy food or ¿junk food¿ (i.e. hyperpalatable food), and rated each image according to three criteria: 1) familiarity of the food displayed; 2) recognisability of the food; and 3) appetisingness of the food. Overall, agreement with a priori categories was high for both healthy and hyperpalatable food images, 87.3% and 87.7% respectively. The food images with the lowest overall ratings (score <7 out of possible 9) were removed from the dataset and the final paradigms each contain 75 images. The healthy food paradigm contains foods from the five core food groups (fruit, vegetables, grains and cereals, meat and meat alternatives, dairy foods), and the hyperpalatable food paradigm contains non-core foods (sweet and savoury discretionary choice foods). The paradigms represent a broad range of commonly consumed foods that will be relevant for prospective projects utilising food cues in Australian adults.

DOI 10.1016/j.foodqual.2020.103885
Citations Scopus - 2Web of Science - 2
Co-authors Manohar Garg, Tracy Burrows, Janelle Skinner
2020 Browne TJ, Hughes DI, Dayas CV, Callister RJ, Graham BA, 'Projection Neuron Axon Collaterals in the Dorsal Horn: Placing a New Player in Spinal Cord Pain Processing', FRONTIERS IN PHYSIOLOGY, 11 (2020) [C1]
DOI 10.3389/fphys.2020.560802
Citations Scopus - 13Web of Science - 4
Co-authors Tyler Browne, Brett Graham, Robert Callister
2020 Browne TJ, Gradwell MA, Iredale JA, Maden JF, Callister RJ, Hughes DI, et al., 'Transgenic Cross-Referencing of Inhibitory and Excitatory Interneuron Populations to Dissect Neuronal Heterogeneity in the Dorsal Horn', Frontiers in Molecular Neuroscience, 13 1-20 (2020) [C1]
DOI 10.3389/fnmol.2020.00032
Citations Scopus - 14Web of Science - 7
Co-authors Robert Callister, Brett Graham, Jacqueline Iredale, Tyler Browne
2019 Skinner JA, Garg ML, Dayas CV, Burrows TL, 'Is weight status associated with peripheral levels of oxytocin? A pilot study in healthy women.', PHYSIOLOGY & BEHAVIOR, 212 (2019) [C1]
DOI 10.1016/j.physbeh.2019.112684
Citations Scopus - 11Web of Science - 5
Co-authors Manohar Garg, Tracy Burrows, Janelle Skinner
2019 Yeoh JW, James MH, Adams CD, Bains JS, Sakurai T, Aston-Jones G, et al., 'Activation of lateral hypothalamic group III metabotropic glutamate receptors suppresses cocaine-seeking following abstinence and normalizes drug-associated increases in excitatory drive to orexin/hypocretin cells', Neuropharmacology, 154 22-33 (2019) [C1]

The perifornical/lateral hypothalamic area (LHA) orexin (hypocretin) system is involved in drug-seeking behavior elicited by drug-associated stimuli. Cocaine exposure is associate... [more]

The perifornical/lateral hypothalamic area (LHA) orexin (hypocretin) system is involved in drug-seeking behavior elicited by drug-associated stimuli. Cocaine exposure is associated with presynaptic plasticity at LHA orexin cells such that excitatory input to orexin cells is enhanced acutely and into withdrawal. These changes may augment orexin cell reactivity to drug-related cues during abstinence and contribute to relapse-like behavior. Studies in hypothalamic slices from drug-naïve animals indicate that agonism of group III metabotropic glutamate receptors (mGluRs) reduces presynaptic glutamate release onto orexin cells. Therefore, we examined the group III mGluR system as a potential target to reduce orexin cell excitability in-vivo, including in animals with cocaine experience. First, we verified that group III mGluRs regulate orexin cell activity in behaving animals by showing that intra-LHA infusions of the selective agonist L-(+)-2-Amino-4-phosphonobutyric acid (L-AP4) reduces c-fos expression in orexin cells following 24 h food deprivation. Next, we extended these findings to show that intra-LHA L-AP4 infusions reduced discriminative stimulus-driven cocaine-seeking following withdrawal. Importantly, L-AP4 had no effect on lever pressing for sucrose pellets or general motoric behavior. Finally, using whole-cell patch-clamp recordings from identified orexin cells in orexin-GFP transgenic mice, we show enhanced presynaptic drive to orexin cells following 14d withdrawal and that this plasticity can be normalized by L-AP4. Together, these data indicate that activation of group III mGluRs in LHA reduces orexin cell activity in vivo and may be an effective strategy to suppress cocaine-seeking behavior following withdrawal. These effects are likely mediated, at least in part, by normalization of presynaptic plasticity at orexin cells that occurs as a result of cocaine exposure. This article is part of the Special Issue entitled ¿Hypothalamic Control of Homeostasis¿.

DOI 10.1016/j.neuropharm.2018.09.033
Citations Scopus - 11Web of Science - 11
Co-authors Brett Graham
2019 Ip CK, Zhang L, Farzi A, Qi Y, Clarke I, Reed F, et al., 'Amygdala NPY Circuits Promote the Development of Accelerated Obesity under Chronic Stress Conditions', Cell Metabolism, 30 111-128.e6 (2019) [C1]

Neuropeptide Y (NPY) exerts a powerful orexigenic effect in the hypothalamus. However, extra-hypothalamic nuclei also produce NPY, but its influence on energy homeostasis is uncle... [more]

Neuropeptide Y (NPY) exerts a powerful orexigenic effect in the hypothalamus. However, extra-hypothalamic nuclei also produce NPY, but its influence on energy homeostasis is unclear. Here we uncover a previously unknown feeding stimulatory pathway that is activated under conditions of stress in combination with calorie-dense food; NPY neurons in the central amygdala are responsible for an exacerbated response to a combined stress and high-fat-diet intervention. Central amygdala NPY neuron-specific Npy overexpression mimics the obese phenotype seen in a combined stress and high-fat-diet model, which is prevented by the selective ablation of Npy. Using food intake and energy expenditure as readouts, we demonstrate that selective activation of central amygdala NPY neurons results in increased food intake and decreased energy expenditure. Mechanistically, it is the diminished insulin signaling capacity on central amygdala NPY neurons under combined stress and high-fat-diet conditions that leads to the exaggerated development of obesity.

DOI 10.1016/j.cmet.2019.04.001
Citations Scopus - 78Web of Science - 63
Co-authors Brett Graham
2019 Borgland SL, Dayas C, 'Hypothalamic control of homeostasis', NEUROPHARMACOLOGY, 154 1-3 (2019)
DOI 10.1016/j.neuropharm.2019.05.029
Citations Scopus - 1Web of Science - 1
2019 Smith KM, Browne TJ, Davis OC, Coyle A, Boyle KA, Watanabe M, et al., 'Calretinin positive neurons form an excitatory amplifier network in the spinal cord dorsal horn', ELIFE, 8 (2019) [C1]
DOI 10.7554/eLife.49190
Citations Scopus - 34Web of Science - 24
Co-authors Tyler Browne, Jacqueline Iredale, Brett Graham, Robert Callister, Phillip Jobling
2019 Skinner JA, Campbell EJ, Dayas CV, Garg ML, Burrows TL, 'The relationship between oxytocin, dietary intake and feeding: A systematic review and meta-analysis of studies in mice and rats', Frontiers in Neuroendocrinology, 52 65-78 (2019) [C1]

The neuropeptide oxytocin has been associated with food intake and feeding behaviour. This systematic review aimed to investigate the impact of oxytocin on dietary intake and feed... [more]

The neuropeptide oxytocin has been associated with food intake and feeding behaviour. This systematic review aimed to investigate the impact of oxytocin on dietary intake and feeding behaviour in rodent studies. Six electronic databases were searched to identify published studies to April 2018. Preclinical studies in mice and rats were included if they reported: (1) a dietary measure (i.e. food or nutrient and/or behaviour (2) an oxytocin measure, and (3) relationship between the two measures. A total of 75 articles (n = 246 experiments) were included, and study quality appraised. The majority of studies were carried out in males (87%). The top three oxytocin outcomes assessed were: exogenous oxytocin administration (n = 126), oxytocin-receptor antagonist administration (n = 46) and oxytocin gene deletion (n = 29). Meta-analysis of exogenous studies in mice (3 studies, n = 43 comparisons) and rats (n = 8 studies, n = 82 comparisons) showed an overall decrease in food intake with maximum effect shown at 2 h post-administration.

DOI 10.1016/j.yfrne.2018.09.002
Citations Scopus - 16Web of Science - 10
Co-authors Janelle Skinner, Manohar Garg, Erin J Campbell, Tracy Burrows
2018 Skinner JA, Garg ML, Dayas CV, Fenton S, Burrows TL, 'Relationship between dietary intake and behaviors with oxytocin: a systematic review of studies in adults.', Nutr Rev, 76 303-331 (2018) [C1]
DOI 10.1093/nutrit/nux078
Citations Scopus - 13Web of Science - 9
Co-authors Tracy Burrows, Janelle Skinner, Manohar Garg, Sasha Fenton
2018 Quinn RK, James MH, Hawkins GE, Brown AL, Heathcote A, Smith DW, et al., 'Temporally specific miRNA expression patterns in the dorsal and ventral striatum of addiction-prone rats', Addiction Biology, 23 631-642 (2018) [C1]

MicroRNAs (miRNAs) within the ventral and dorsal striatum have been shown to regulate addiction-relevant behaviours. However, it is unclear how cocaine experience alone can alter ... [more]

MicroRNAs (miRNAs) within the ventral and dorsal striatum have been shown to regulate addiction-relevant behaviours. However, it is unclear how cocaine experience alone can alter the expression of addiction-relevant miRNAs within striatal subregions. Further, it is not known whether differential expression of miRNAs in the striatum contributes to individual differences in addiction vulnerability. We first examined the effect of cocaine self-administration on the expression of miR-101b, miR-137, miR-212 and miR-132 in nucleus accumbens core and nucleus accumbens shell (NAcSh), as well as dorsomedial striatum and dorsolateral striatum (DLS). We then examined the expression of these same miRNAs in striatal subregions of animals identified as being ¿addiction-prone¿, either immediately following self-administration training or following extinction and relapse testing. Cocaine self-administration was associated with changes in miRNA expression in a regionally discrete manner within the striatum, with the most marked changes occurring in the nucleus accumbens core. When we examined the miRNA profile of addiction-prone rats following self-administration, we observed increased levels of miR-212 in the dorsomedial striatum. After extinction and relapse testing, addiction-prone rats showed significant increases in the expression of miR-101b, miR-137, miR-212 and miR-132 in NAcSh, and miR-137 in the DLS. This study identifies temporally specific changes in miRNA expression consistent with the engagement of distinct striatal subregions across the course of the addiction cycle. Increased dysregulation of miRNA expression in NAcSh and DLS at late stages of the addiction cycle may underlie habitual drug seeking, and may therefore aid in the identification of targets designed to treat addiction.

DOI 10.1111/adb.12520
Citations Scopus - 32Web of Science - 25
Co-authors Douglas Smith, Ajheathcote, Guy Hawkins, Murray Cairns
2018 Burrows T, Kay-Lambkin F, Pursey K, Skinner J, Dayas C, 'Food addiction and associations with mental health symptoms: a systematic review with meta-analysis', Journal of Human Nutrition and Dietetics, 31 544-572 (2018) [C1]

Background: The present study systematically reviewed the literature aiming to determine the relationships between food addiction, as measured by the Yale Food Addiction Scale (YF... [more]

Background: The present study systematically reviewed the literature aiming to determine the relationships between food addiction, as measured by the Yale Food Addiction Scale (YFAS), and mental health symptoms. Methods: Nine databases were searched using keywords. Studies were included if they reported: (i) YFAS diagnosis or symptom score and (ii) a mental health outcome, as well as the association between (i) and (ii). In total, 51 studies were included. Results: Through meta-analysis, the mean prevalence of food addiction diagnosis was 16.2%, with an average of 3.3 (range 2.85¿3.92) food addiction symptoms being reported. Subanalyses revealed that the mean number of food addiction symptoms in populations seeking treatment for weight loss was 3.01 (range 2.65¿3.37) and this was higher in groups with disordered eating (mean 5.2 3.6¿6.7). Significant positive correlations were found between food addiction and binge eating [mean r¿=¿0.602 (0.557¿0.643), P¿<¿0.05], depression, anxiety and food addiction [mean r¿=¿0.459 (0.358¿0.550), r¿=¿0.483 (0.228¿0.676), P¿<¿0.05, respectively]. Conclusions: A significant, positive relationship exists between food addiction and mental health symptoms, although the results of the present study highlight the complexity of this relationship.

DOI 10.1111/jhn.12532
Citations Scopus - 153Web of Science - 113
Co-authors Kirrilly Pursey, Tracy Burrows, Frances Kaylambkin, Janelle Skinner
2017 Campbell EJ, Mitchell CS, Adams CD, Yeoh JW, Hodgson DM, Graham BA, Dayas CV, 'Chemogenetic activation of the lateral hypothalamus reverses early life stress-induced deficits in motivational drive', European Journal of Neuroscience, 46 2285-2296 (2017) [C1]

Altered motivated behaviour is a cardinal feature of several neuropsychiatric conditions including mood disorders. One well-characterized antecedent to the development of mood dis... [more]

Altered motivated behaviour is a cardinal feature of several neuropsychiatric conditions including mood disorders. One well-characterized antecedent to the development of mood disorders is exposure to early life stress (ELS). A key brain substrate controlling motivated behaviour is the lateral hypothalamus (LH). Here, we examined the effect of ELS on LH activation and the motivation to self-administer sucrose. We tested whether chemogenetic activation of LH circuits could modify sucrose responding in ELS rats and examined the impact on LH cell populations. Male rat pups were maternally separated for 0 or 3¿h on postnatal days 2¿14. During adolescence, rats received bilateral injections of hM3D(Gq), the excitatory designer receptor exclusively activated by designer drugs, into LH. In adulthood, rats were trained to self-administer sucrose and tested under a progressive ratio schedule to determine their motivation for reward following injection with either vehicle or 5¿mg/kg clozapine-N-oxide. Brains were processed for Fos-protein immunohistochemistry. ELS significantly suppressed lever responding for sucrose, indicating a long-lasting impact of ELS on motivation circuits. hM3D(Gq) activation of LH increased responding, normalizing deficits in ELS rats, and increased Fos-positive orexin and MCH cell numbers within LH. Our findings indicate that despite being susceptible to environmental stressors, LH circuits retain the capacity to overcome ELS-induced deficits in motivated behaviour.

DOI 10.1111/ejn.13674
Citations Scopus - 14Web of Science - 10
Co-authors Brett Graham, Deborah Hodgson, Erin J Campbell
2017 Campbell EJ, Barker DJ, Nasser HM, Kaganovsky K, Dayas CV, Marchant NJ, 'Cue-induced food seeking after punishment is associated with increased fos expression in the lateral hypothalamus and basolateral and medial amygdala', Behavioral Neuroscience, 131 155-167 (2017) [C1]

In humans, relapse to unhealthy eating habits following dieting is a significant impediment to obesity treatment. Food-associated cues are one of the main triggers of relapse to u... [more]

In humans, relapse to unhealthy eating habits following dieting is a significant impediment to obesity treatment. Food-associated cues are one of the main triggers of relapse to unhealthy eating during self-imposed abstinence. Here we report a behavioral method examining cue-induced relapse to food seeking following punishment-induced suppression of food taking. We trained male rats to lever press for food pellets that were delivered after a 10-s conditional stimulus (CS) (appetitive). Following training, 25% of reinforced lever presses resulted in the presentation of a compound stimulus consisting of a novel CS (aversive) and the appetitive CS followed by a pellet and footshock. After punishment-imposed abstinence, we tested the rats in an extinction test where lever pressing resulted in the presentation of either the appetitive or aversive CS. We then compared activity of lateral hypothalamus (LH) and associated extrahypothalamic regions following this test. We also assessed Fos expression in LH orexin and GABA neurons. We found that cue-induced relapse of food seeking on test was higher in rats tested with the appetitive CS compared to the aversive CS. Relapse induced by the appetitive CS was associated with increased Fos expression in LH, caudal basolateral amygdala (BLA), and medial amygdala (MeA). This relapse was also associated with increased Fos expression in LH orexin and VGAT-expressing neurons. These data show that relapse to food seeking can be induced by food-associated cues after punishment-imposed abstinence, and this relapse is associated with increased activity in LH, caudal BLA, and MeA.

DOI 10.1037/bne0000185
Citations Scopus - 17Web of Science - 11
Co-authors Erin J Campbell
2017 Burrows T, Hides L, Brown R, Dayas CV, Kay-Lambkin F, 'Differences in Dietary Preferences, Personality and Mental Health in Australian Adults with and without Food Addiction', NUTRIENTS, 9 (2017) [C1]
DOI 10.3390/nu9030285
Citations Scopus - 70Web of Science - 49
Co-authors Tracy Burrows, Frances Kaylambkin
2016 Parkinson GM, Dayas CV, Smith DW, 'Perturbed cholesterol homeostasis in aging spinal cord', Neurobiology of Aging, 45 123-135 (2016) [C1]

The spinal cord is vital for the processing of sensorimotor information and for its propagation to and from both the brain and the periphery. Spinal cord function is affected by a... [more]

The spinal cord is vital for the processing of sensorimotor information and for its propagation to and from both the brain and the periphery. Spinal cord function is affected by aging, however, the mechanisms involved are not well-understood. To characterize molecular mechanisms of spinal cord aging, microarray analyses of gene expression were performed on cervical spinal cords of aging rats. Of the metabolic and signaling pathways affected, cholesterol-associated pathways were the most comprehensively altered, including significant downregulation of cholesterol synthesis-related genes and upregulation of cholesterol transport and metabolism genes. Paradoxically, a significant increase in total cholesterol content was observed-likely associated with cholesterol ester accumulation. To investigate potential mechanisms for the perturbed cholesterol homeostasis, we quantified the expression of myelin and neuroinflammation-associated genes and proteins. Although there was minimal change in myelin-related expression, there was an increase in phagocytic microglial and astrogliosis markers, particularly in the white matter. Together, these results suggest that perturbed cholesterol homeostasis, possibly as a result of increased inflammatory activation in spinal cord white matter, may contribute to impaired spinal cord function with aging.

DOI 10.1016/j.neurobiolaging.2016.05.017
Citations Scopus - 9Web of Science - 9
Co-authors Douglas Smith
2016 James MH, Quinn RK, Ong LK, Levi EM, Smith DW, Dickson PW, Dayas CV, 'Rapamycin reduces motivated responding for cocaine and alters GluA1 expression in the ventral but not dorsal striatum', European Journal of Pharmacology, 784 147-154 (2016) [C1]

The mechanistic target of rapamycin complex 1 (mTORC1) regulates synaptic protein synthesis and therefore synaptic function and plasticity. A role for mTORC1 has recently been dem... [more]

The mechanistic target of rapamycin complex 1 (mTORC1) regulates synaptic protein synthesis and therefore synaptic function and plasticity. A role for mTORC1 has recently been demonstrated for addiction-related behaviors. For example, central or intra-accumbal injections of the mTORC1 inhibitor rapamycin attenuates several indices of cocaine-seeking including progressive ratio (PR) responding and reinstatement. These behavioral effects are associated with decreased mTORC1 activity and synaptic protein translation in the nucleus accumbens (NAC) and point to a possible therapeutic role for rapamycin in the treatment of addiction. Currently, it is unclear whether similar behavioral and biochemical effects can be achieved by administering rapamycin systemically, which represents a more clinically-appropriate route of administration. Here, we assessed the effects of repeated, systemic administration of rapamycin (10 mg/kg, i.p.) on PR responding for cocaine. We also assessed whether systemic rapamycin was associated with changes in measures of mTORC1 activity and GluA1 expression in the ventral and dorsal striatum. We report that systemic rapamycin treatment reduced PR breakpoints to levels comparable to intra-NAC rapamycin. Systemic rapamycin treatment also reduced phosphorylated p70S6K and GluA1 AMPARs within the NAC but not dorsal striatum. Thus, systemic administration of rapamycin is as effective at reducing drug seeking behavior and measures of mTORC1 activity compared to direct accumbal application and may therefore represent a possible therapeutic option in the treatment of addiction. Possible caveats of this treatment approach are discussed.

DOI 10.1016/j.ejphar.2016.05.013
Citations Scopus - 23Web of Science - 22
Co-authors Douglas Smith, Phil Dickson
2015 Quinn RK, Brown AL, Goldie BJ, Levi EM, Dickson PW, Smith DW, et al., 'Distinct miRNA expression in dorsal striatal subregions is associated with risk for addiction in rats', Translational Psychiatry, 5 (2015) [C1]

Recently, we published data using an animal model that allowed us to characterize animals into two groups, addiction vulnerable and addiction resilient, where we identified that a... [more]

Recently, we published data using an animal model that allowed us to characterize animals into two groups, addiction vulnerable and addiction resilient, where we identified that addiction/relapse vulnerability was associated with deficits in synaptic plasticityassociated gene expression in the dorsal striatum (DS). Notable was the strong reduction in expression for activity-regulated cytoskeleton-associated protein (Arc) considered a master regulator of synaptic plasticity. In the present study, we confirmed that Arc messenger RNA was significantly decreased in the DS, but importantly, we identified that this reduction was restricted to the dorsomedial (DMS) and not dorsolateral striatum (DLS). There is recent evidence of microRNA (miRNA)-associated posttranscriptional suppression of Arc and animal models of addiction have identified a key role for miRNA in the regulation of addiction-relevant genes. In further support of this link, we identified several differentially expressed miRNA with the potential to influence addiction-relevant plasticity genes, including Arc. A key study recently reported that miR-212 expression is protective against compulsive cocaine-seeking. Supporting this hypothesis, we found that miR-212 expression was significantly reduced in the DMS but not DLS of addiction-vulnerable animals. Together, our data provide strong evidence that miRNA promote ongoing plasticity deficits in the DS of addiction-vulnerable animals.

DOI 10.1038/tp.2014.144
Citations Scopus - 28Web of Science - 24
Co-authors Douglas Smith, Murray Cairns, Phil Dickson
2015 Campbell EJ, Watters SM, Zouikr I, Hodgson DM, Dayas CV, 'Recruitment of hypothalamic orexin neurons after formalin injections in adult male rats exposed to a neonatal immune challenge', Frontiers in Neuroscience, 9 (2015) [C1]

Exposure to early life physiological stressors, such as infection, is thought to contribute to the onset of psychopathology in adulthood. In animal models, injections of the bacte... [more]

Exposure to early life physiological stressors, such as infection, is thought to contribute to the onset of psychopathology in adulthood. In animal models, injections of the bacterial immune challenge, lipopolysaccharide (LPS), during the neonatal period has been shown to alter both neuroendocrine function and behavioural pain responses in adulthood. Interestingly, recent evidence suggests a role for the lateral hypothalamic peptide orexin in stress and nociceptive processing. However, whether neonatal LPS exposure affects the reactivity of the orexin system to formalin-induced inflammatory pain in later life remains to be determined. Male Wistar rats (n=13) were exposed to either LPS or saline (0.05mg/kg, i.p) on postnatal days (PND) 3 and 5. On PND 80-97, all rats were exposed to a subcutaneous hindpaw injection of 2.25% formalin. Following behavioural testing, animals were perfused and brains processed for Fos-protein and orexin immunohistochemistry. Rats treated with LPS during the neonatal period exhibited decreased licking behaviours during the interphase of the formalin test, the period typically associated with the active inhibition of pain, and increased grooming responses to formalin in adulthood. Interestingly, these behavioural changes were accompanied by an increase in the percentage of Fos-positive orexin cells in the dorsomedial and perifornical hypothalamus in LPS-exposed animals. Similar increases in Fos-protein were also observed in stress and pain sensitive brain regions that receive orexinergic inputs. These findings highlight a potential role for orexin in the behavioural responses to pain and provide further evidence that early life stress can prime the circuitry responsible for these responses in adulthood.

DOI 10.3389/fnins.2015.00065
Citations Scopus - 12Web of Science - 12
Co-authors Erin J Campbell, Deborah Hodgson
2015 Parkinson GM, Dayas CV, Smith DW, 'Age-related gene expression changes in substantia nigra dopamine neurons of the rat.', Mech Ageing Dev, 149 41-49 (2015) [C1]
DOI 10.1016/j.mad.2015.06.002
Citations Scopus - 16Web of Science - 12
Co-authors Douglas Smith
2014 James MH, Quinn RK, Ong LK, Levi EM, Charnley JL, Smith DW, et al., 'mTORC1 inhibition in the nucleus accumbens 'protects' against the expression of drug seeking and 'relapse' and is associated with reductions in GluA1 AMPAR and CAMKIIa levels.', Neuropsychopharmacology, 39 1694-1702 (2014) [C1]
DOI 10.1038/npp.2014.16
Citations Scopus - 29Web of Science - 24
Co-authors Douglas Smith, Phil Dickson
2014 Goldie BJ, Dun MD, Lin M, Smith ND, Verrills NM, Dayas CV, Cairns MJ, 'Activity-associated miRNA are packaged in Map1b-enriched exosomes released from depolarized neurons.', Nucleic Acids Research, 42 9195-9208 (2014) [C1]
DOI 10.1093/nar/gku594
Citations Scopus - 227Web of Science - 178
Co-authors Matt Dun, Murray Cairns, Nikki Verrills
2014 Parkinson GM, Dayas CV, Smith DW, 'Increased mitochondrial DNA deletions in substantia nigra dopamine neurons of the aged rat.', Current aging science, 7 155-160 (2014) [C2]
DOI 10.2174/1874609808666150122150850
Citations Scopus - 18
Co-authors Douglas Smith
2014 Zouikr I, James MH, Campbell EJ, Clifton VL, Beagley KW, Dayas CV, Hodgson DM, 'Altered formalin-induced pain and fos induction in the periaqueductal grey of preadolescent rats following neonatal LPS exposure', PLoS ONE, 9 (2014) [C1]

Animal and human studies have demonstrated that early pain experiences can produce alterations in the nociceptive systems later in life including increased sensitivity to mechanic... [more]

Animal and human studies have demonstrated that early pain experiences can produce alterations in the nociceptive systems later in life including increased sensitivity to mechanical, thermal, and chemical stimuli. However, less is known about the impact of neonatal immune challenge on future responses to noxious stimuli and the reactivity of neural substrates involved in analgesia. Here we demonstrate that rats exposed to Lipopolysaccharide (LPS; 0.05 mg/kg IP, Salmonella enteritidis) during postnatal day (PND) 3 and 5 displayed enhanced formalin-induced flinching but not licking following formalin injection at PND 22. This LPS-induced hyperalgesia was accompanied by distinct recruitment of supraspinal regions involved in analgesia as indicated by significantly attenuated Fos-protein induction in the rostral dorsal periaqueductal grey (DPAG) as well as rostral and caudal axes of the ventrolateral PAG (VLPAG). Formalin injections were associated with increased Fos-protein labelling in lateral habenula (LHb) as compared to medial habenula (MHb), however the intensity of this labelling did not differ as a result of neonatal immune challenge. These data highlight the importance of neonatal immune priming in programming inflammatory pain sensitivity later in development and highlight the PAG as a possible mediator of this process. © 2014 Zouikr et al.

DOI 10.1371/journal.pone.0098382
Citations Scopus - 19Web of Science - 17
Co-authors Erin J Campbell, Deborah Hodgson
2014 Yeoh JW, Campbell EJ, James MH, Graham BA, Dayas CV, 'Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls.', Front Neurosci, 8 36 (2014) [C1]
DOI 10.3389/fnins.2014.00036
Citations Scopus - 74Web of Science - 65
Co-authors Erin J Campbell, Brett Graham
2014 Yeoh JW, James MH, Graham BA, Dayas CV, 'Electrophysiological characteristics of paraventricular thalamic (PVT) neurons in response to cocaine and cocaine- and amphetamine-regulated transcript (CART)', FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 8 (2014) [C1]
DOI 10.3389/fnbeh.2014.00280
Citations Scopus - 26Web of Science - 25
Co-authors Brett Graham
2014 James MH, Campbell EJ, Walker FR, Smith DW, Richardson HN, Hodgson DM, Dayas CV, 'Exercise reverses the effects of early life stress on orexin cell reactivity in male but not female rats', Frontiers in Behavioral Neuroscience, 8 (2014) [C1]
DOI 10.3389/fnbeh.2014.00244
Citations Scopus - 59Web of Science - 49
Co-authors Deborah Hodgson, Douglas Smith, Rohan Walker, Erin J Campbell
2013 James MH, Dayas CV, 'What about me ...? The PVT: a role for the paraventricular thalamus (PVT) in drug-seeking behavior', FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 7 (2013) [C3]
DOI 10.3389/fnbeh.2013.00018
Citations Scopus - 49Web of Science - 44
2013 Cahif A, Parkinson GM, Dayas CV, Smith DW, 'Characterisation of mitochondrial DNA deletions by long-PCR in central nervous system regions of young, middle- and old-aged rats.', Current Aging Science, 6 232-238 (2013) [C1]
Citations Scopus - 4
Co-authors Douglas Smith
2013 Brown AL, Day TA, Dayas CV, Smith DW, 'Purity and Enrichment of Laser-Microdissected Midbrain Dopamine Neurons', BIOMED RESEARCH INTERNATIONAL, 2013 (2013) [C1]
DOI 10.1155/2013/747938
Citations Scopus - 11Web of Science - 9
Co-authors Douglas Smith
2012 James MH, Yeoh JW, Graham B, Dayas C, 'Insights for Developing Pharmacological Treatments for Psychostimulant Relapse Targeting Hypothalamic Peptide Systems.', Journal of Addiction Research and Therapy, 01 1-14 (2012)
Co-authors Brett Graham
2012 Yeoh JW, James MH, Jobling P, Bains JS, Graham BA, Dayas CV, 'Cocaine potentiates excitatory drive in the perifornical/lateral hypothalamus', Journal of Physiology, 590 3677-3689 (2012) [C1]
Citations Scopus - 48Web of Science - 42
Co-authors Brett Graham, Phillip Jobling
2012 Dayas CV, Smith DW, Dunkley PR, 'An emerging role for the mammalian Target of Rapamycin (mTOR) in 'pathological' protein translation: Relevance to cocaine addiction', Frontiers in Pharmacology, 3 1-12 (2012) [C1]
Citations Scopus - 31Web of Science - 29
Co-authors Peter Dunkley, Douglas Smith
2011 James MH, Charnley JL, Flynn JR, Smith DW, Dayas CV, 'Propensity to 'relapse' following exposure to cocaine cues is associated with the recruitment of specific thalamic and epithalamic nuclei', Neuroscience, 199 235-242 (2011) [C1]
Citations Scopus - 68Web of Science - 61
Co-authors Jamie Flynn, Douglas Smith
2011 James MH, Charnley JL, Levi EM, Jones E, Yeoh JW, Smith DW, Dayas CV, 'Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking', International Journal of Neuropsychopharmacology, 14 684-690 (2011) [C1]
DOI 10.1017/s1461145711000423
Citations Scopus - 119Web of Science - 108
Co-authors Douglas Smith
2011 Brown AL, Flynn JR, Smith DW, Dayas CV, 'Down-regulated striatal gene expression for synaptic plasticity-associated proteins in addiction and relapse vulnerable animals', International Journal of Neuropsychopharmacology, 14 1099-1110 (2011) [C1]
Citations Scopus - 30Web of Science - 29
Co-authors Jamie Flynn, Douglas Smith
2010 James MH, Charnley JL, Jones E, Levi E, Yeoh JW, Flynn JR, et al., 'Cocaine- and amphetamine-regulated transcript (CART) signaling within the paraventricular thalamus modulates cocaine-seeking behaviour', Plos One, 5 e12980 (2010) [C1]
DOI 10.1371/journal.pone.0012980
Citations Scopus - 95Web of Science - 88
Co-authors Jamie Flynn, Douglas Smith
2009 Martin-Fardon R, Baptista MAS, Dayas CV, Weiss F, 'Dissociation of the effects of MTEP [3-[(2-methyl-1,3-thiazol-4-yl)ethynyl] piperidine] on conditioned reinstatement and reinforcement: Comparison between cocaine and a conventional reinforcer', Journal of Pharmacology and Experimental Therapeutics, 329 1084-1090 (2009) [C1]
DOI 10.1124/jpet.109.151357
Citations Scopus - 85Web of Science - 76
2008 Dayas C, McGranahan T, Martin-Fardon F, Weiss F, 'Stimuli Linked to Ethanol Availability Activate Hypothalamic CART and Orexin Neurons in a Reinstatement Model of Relapse', Biological Psychiatry, 63 152-157 (2008) [C1]
DOI 10.1016/j.biopsych.2007.02.002
Citations Scopus - 186Web of Science - 173
2007 Dayas C, Liu X, Simms J, Weiss F, 'Distinct Patterns of Neural Activation Associated with Ethanol Seeking: Effects of Naltrexone', Biological Psychiatry, 61 979-989 (2007) [C1]
DOI 10.1016/j.biopsych.2006.07.034
Citations Scopus - 125Web of Science - 114
2006 Xhao Y, Dayas C, Aujla H, Baptista MA, Martin-Fardon R, Weiss F, 'Activation of group II metabotropic glutamate receptors attenuates both stress and cue-induced ethanol-seeking and modulates c-fos expression in the hippocampus and amygdala', The Journal of Neuroscience, 26 9967-9974 (2006) [C1]
DOI 10.1523/JNEUROSCI.2384-06.2006
Citations Scopus - 163Web of Science - 152
2005 Breese GR, Chu K, Dayas C, Funk D, Knapp DJ, Koob GF, et al., 'Stress enhancement of craving during sobriety: A risk for relapse', Alcoholism: Clinical and Experimental Research, 29 185-195 (2005) [C1]
DOI 10.1097/01.ALC.0000153544.83656.3C
Citations Scopus - 216Web of Science - 184
2004 Dayas C, Buller KM, Day TA, 'Hypothalamic paraventricular nucleus neurons regulate medullary catecholamine cell responses to restraint stress', Journal of Comparative Neurology, 478 22-34 (2004) [C1]
DOI 10.1002/cne.20259
Citations Scopus - 44Web of Science - 42
2004 Dayas C, Martin-Fardon R, Thorsell A, Weiss F, 'Chronic footshock, but not a physiological stressor, suppresses the alcohol deprivation effect in dependent rats', Alcohol and Alcoholism, 39 190-196 (2004) [C1]
DOI 10.1093/alcalc/agh046
Citations Scopus - 16Web of Science - 15
2003 Buller KM, Dayas C, Day TA, 'Descending pathways from the paraventricular nucleus contribute to the recruitment of brainstem nuclei following a systemic immune challenge', Neuroscience, 118 189-203 (2003) [C1]
DOI 10.1016/S0306-4522(02)00808-4
Citations Scopus - 45Web of Science - 39
2002 Dayas C, Day TA, 'Opposing Roles For Medial And Central Amygdala In The Initiation Of Noradrenergic Cell Responses To A Psychological Stressor.', European Journal of Neuroscience, 15 1712-1718 (2002) [C1]
Citations Scopus - 68Web of Science - 58
2001 Buller K, Xu YY, Dayas C, Day T, 'Dorsal and ventral medullary catecholamine cell groups contribute differentially to systemic interleukin-1 beta-induced hypothalamic pituitary adrenal axis responses', NEUROENDOCRINOLOGY, 73 129-138 (2001)
DOI 10.1159/000054629
Citations Scopus - 89Web of Science - 77
2001 Dayas CV, Buller KM, Day TA, 'Medullary neurones regulate hypothalamic corticotropin-releasing factor cell responses to an emotional stressor', NEUROSCIENCE, 105 707-719 (2001)
DOI 10.1016/S0306-4522(01)00213-5
Citations Scopus - 87Web of Science - 76
2001 Dayas CV, Buller KM, Crane JW, Xu Y, Day TA, 'Stressor categorization: Acute physical and psychological stressors elicit distinctive recruitment patterns in the amygdala and in medullary noradrenergic cell groups', European Journal of Neuroscience, 14 1143-1152 (2001) [C1]
Citations Scopus - 429Web of Science - 387
2000 Dayas CV, Xu Y, Buller KM, Day TA, 'Effects of chronic oestrogen replacement on stress-induced activation of hypothalamic-pituitary-adrenal axis control pathways', JOURNAL OF NEUROENDOCRINOLOGY, 12 784-794 (2000)
DOI 10.1046/j.1365-2826.2000.00527.x
Citations Scopus - 93Web of Science - 78
1999 Dayas CV, Buller KM, Day TA, 'Neuroendocrine responses to an emotional stressor: Evidence for involvement of the medial but not the central amygdala', European Journal of Neuroscience, 11 2312-2322 (1999) [C1]
Citations Scopus - 274Web of Science - 244
Show 60 more journal articles

Conference (22 outputs)

Year Citation Altmetrics Link
2023 Dayas CV, 'THE PVN UNDER THE INFLUENCE', ALCOHOL (2023)
2022 Brown AL, Hinwood M, Campbell E, Chen C, Dayas CV, Dunlop AJ, et al., 'Incorporating neuroimaging into addiction neuromodulation research', DRUG AND ALCOHOL REVIEW (2022)
Co-authors A Dunlop, Saadallah Ramadan, Madeleine Hinwood, Bryan Paton
2021 Katz-Barber M, Manning E, Fisher S, Bains J, Graham B, Dayas C, 'Emerging evidence of dysregulated stress reactivity in hypothalamic corticotrophin-releasing hormone (CRH) neurons following cocaine exposure', Online (2021)
Co-authors Brett Graham
2021 Katz-Barber M, Manning E, Fisher S, Bains J, Graham B, Dayas C, 'Stress reactivity of hypothalamic corticotrophin-releasing hormone (CRH) neurons following cocaine exposure', Online (2021)
Co-authors Brett Graham
2021 Brown AL, Hinwood M, Dayas CV, Martin J, Galettis P, Paton B, Dunlop AJ, 'INHIBITION OF THE MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1 SIGNALLING PATHWAY FOR TREATMENT OF MODERATE-SEVERE ALCOHOL USE DISORDER - AN EARLY PHASE SAFETY AND FEASIBILITY PILOT STUDY', DRUG AND ALCOHOL REVIEW (2021)
Co-authors Peter Galettis, Madeleine Hinwood, Bryan Paton, Jenniferh Martin, A Dunlop
2021 Bourke M, Pahalawatta U, Lun E, Fiorentino M, Rattan R, Bourke B, et al., 'The Future of Post Graduate Anatomy Education', Online (2021)
Co-authors Amanda Dawson
2021 Lun E, Bourke M, Pahalawatta U, Bourke B, Katib N, Rattan R, et al., 'SECTRA: The Future of Radiology Anatomy Education', Melbourne (2021)
Co-authors Michael D Bourke, Amanda Dawson
2021 Lun E, Bourke M, Pahalawatta U, Bourke B, Katib N, Fiorentino M, Rattan R, 'SECTRA: Embracing the Future of Anatomy Education', Virtual New Zealand (2021)
Co-authors Michael D Bourke, Amanda Dawson
2021 Dayas CV, 'CELLULAR ACTIVATION OF LATERAL HYPOTHALAMIC CELLS PROMOTES REVERSAL OF MOTIVATIONAL DEFICITS BROUGHTON BY EARLY LIFE ADVERSITY', ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2021)
2019 Katz-Barber M, Sherwood C, Mitchell C, Burton N, Fisher S, Bains J, et al., 'That's Stressful! Characterising the Neurobiology of Addiction', The Florey Institute of Neuroscience and Mental Health (2019)
Co-authors Brett Graham
2019 Greco L, Fisher SD, Pearl A, Akbari L, Geaghan M, Kenny PJ, et al., 'OVER EXPRESSION OF THE SCHIZOPHRENIA-ASSOCIATED RISK GENE MIR-137 IN THE DORSAL STRIATUM PROMOTES COMPULSIVE COCAINE-SEEKING', EUROPEAN NEUROPSYCHOPHARMACOLOGY, Los Angeles, CA (2019)
DOI 10.1016/j.euroneuro.2019.07.205
Co-authors Laura Greco, Murray Cairns
2012 James MH, Charnley JL, Levi EM, Dunkley PR, Smith DW, Dickson PW, Dayas CV, 'A role for the mTOR pathway in the development of addiction', Abstracts. Australian Neuroscience Society 32nd Annual Meeting, Gold Coast, Queensland (2012) [E3]
Co-authors Peter Dunkley, Douglas Smith, Phil Dickson
2012 Brown AL, Flynn JR, Dayas CV, Smith DW, 'Altered gene expression in cell signalling pathways of midbrain dopamine neurons from addiction and relapse vulnerable animals', Drug and Alcohol Review: Abstracts of the Australasian Professional Society on Alcohol and other Drugs Conference 2012, Melbourne, Vic (2012) [E3]
Co-authors Douglas Smith, Jamie Flynn
2012 Dayas CV, Quinn RK, Goldie BJ, Brown AM, Levi EM, Smith DW, Cairns MJ, 'Association of miRNAs with addiction-relevant synaptic plasticity genes', Abstract Book. Biological Psychiatry Australia Scientific Meeting, Parkville, Vic (2012) [E3]
Co-authors Douglas Smith, Murray Cairns
2012 Campbell EJ, James MH, Sominsky Bar L, Hodgson DM, Dayas CV, 'Adult stress unmasks altered orexin cell functioning in maternally separated rats: Implications for the development of psychopathologies', Abstract Book. Biological Psychiatry Australia Scientific Meeting, Parkville, Vic (2012) [E3]
Co-authors Deborah Hodgson
2010 Dayas CV, 'BRAIN MECHANISMS ASSOCIATED WITH THE DEVELOPMENT OF PSYCHOSTIMULANT ADDICTION', DRUG AND ALCOHOL REVIEW (2010) [E3]
2008 Dayas CV, 'The neurobiology of drug relapse: A role for hypothalamic 'feeding' peptides in drug relapse?', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
2007 Dayas CV, McGranahan TM, Martin-Fardon R, Weiss F, 'Hypothalamic feeding-related peptides are recruited in a reinstatement model of ethanol relapse (Poster)', 7th IBRO 2007 World Congress of Neuroscience Program, Melbourne (2007) [E3]
2007 Weiss F, Dayas CV, 'Alcohol cue exposure produces distinct patterns of neural activation implications for alcohol craving and relapse', ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Chicago, IL (2007)
2005 Zhao Y, Dayas CV, Weiss F, 'Effects of the metabotropic Glutamate 2/3 agonist LY379268 on reinstatement of ethanol-seeking induced by alcohol-associated environmental stimuli and foot-shock stress', ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Santa Barbara, CA (2005)
Citations Web of Science - 1
2005 Dayas CV, Zhao Y, Weiss F, ''Anti-relapse' effects of the metabotropic glutamate 2/3 agonist LY379268 am associated with increased c-fos expression in the central amygdala', ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Santa Barbara, CA (2005)
1999 Day TA, Buller KM, Xu Y, Dayas CV, Crane JW, 'Separation of neural pathways mediating HPA axis responses to emotional and physical stressors', CONTROL MECHANISMS OF STRESS AND EMOTION: NEUROENDOCRINE-BASED STUDIES, KITAKYUSHU, JAPAN (1999)
Citations Web of Science - 4
Show 19 more conferences

Preprint (3 outputs)

Year Citation Altmetrics Link
2023 Mitchell C, Campbell E, Fisher S, Stanton L, Burton N, Pearl A, et al., 'Optogenetic recruitment of hypothalamic corticotrophin-releasing-hormone (CRH) neurons reduces motivational drive (2023)
DOI 10.1101/2023.02.03.527084
Co-authors Brett Graham, Lizzie Manning, Erin J Campbell
2023 Iredale J, Pearl A, Callister R, Dayas C, Manning E, Graham B, ' Optical Von-Frey method to determine nociceptive thresholds: a novel paradigm for preclinical pain assessment and analgesic screening (2023)
DOI 10.1101/2023.11.02.565390
Co-authors Brett Graham, Robert Callister, Lizzie Manning, Jacqueline Iredale
2021 Greco L, Reay W, Dayas C, Cairns M, 'Pairwise genetic meta-analyses between schizophrenia and substance dependence phenotypes reveals novel association signals (2021)
DOI 10.1101/2021.09.12.21263471
Co-authors Murray Cairns, Laura Greco, William Reay Uon
Edit

Grants and Funding

Summary

Number of grants 42
Total funding $7,282,057

Click on a grant title below to expand the full details for that specific grant.


20241 grants / $50,000

Newcastle Human Organoid Program for Effective New Therapies (New HOPE – New Therapies) $50,000

Funding body: Jessie Speight Bequest

Funding body Jessie Speight Bequest
Project Team Professor Jay Horvat, Professor Chris Dayas, Conjoint Associate Professor Christopher Grainge, Doctor Gerard Kaiko, Professor Simon Keely
Scheme Research Funding
Role Investigator
Funding Start 2024
Funding Finish 2024
GNo G2400300
Type Of Funding Scheme excluded from IGS
Category EXCL
UON Y

20232 grants / $1,150,676

A new mechanism for targeting stress-related mental health disorders$836,199

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Chris Dayas, Dr Jaideep Bains, Doctor Lizzie Manning
Scheme Ideas Grants
Role Lead
Funding Start 2023
Funding Finish 2026
GNo G2200413
Type Of Funding C1100 - Aust Competitive - NHMRC
Category 1100
UON Y

Neural circuit control of effort under stress$314,477

Funding body: ARC (Australian Research Council)

Funding body ARC (Australian Research Council)
Project Team Doctor Lizzie Manning, Professor Chris Dayas, Doctor Susannah Tye
Scheme Discovery Projects
Role Investigator
Funding Start 2023
Funding Finish 2025
GNo G2300155
Type Of Funding C1200 - Aust Competitive - ARC
Category 1200
UON Y

20224 grants / $885,350

BioSHeM: A High-Resolution Imaging and Spectroscopic Helium Atom Microscope$420,347

Funding body: ARC (Australian Research Council)

Funding body ARC (Australian Research Council)
Project Team Professor Paul Dastoor, Laureate Professor Roger Smith, Professor Alan Brichta, Professor Chris Dayas, Associate Professor Ian Grainge, Jamie Quinton, Elizabeth Dinsdale, Prof Peter Cumpson, Jane Evans, Elizabeth Dinsdale, Jane Evans, Jamie Quinton
Scheme Linkage Infrastructure Equipment & Facilities (LIEF)
Role Investigator
Funding Start 2022
Funding Finish 2022
GNo G2100336
Type Of Funding Scheme excluded from IGS
Category EXCL
UON Y

Hunger flexibly modifies hypothalamic neural circuits responding to threat.$375,003

Funding body: ARC (Australian Research Council)

Funding body ARC (Australian Research Council)
Project Team Professor Chris Dayas, Prof Zane Andrews, Professor Brett Graham, Doctor Lizzie Manning
Scheme Discovery Projects
Role Lead
Funding Start 2022
Funding Finish 2025
GNo G2200223
Type Of Funding C1200 - Aust Competitive - ARC
Category 1200
UON Y

BioSHeM: A High-Resolution Imaging and Spectroscopic Helium Atom Microscope$50,000

Funding body: Flinders University

Funding body Flinders University
Project Team Professor Paul Dastoor, Laureate Professor Roger Smith, Professor Alan Brichta, Professor Chris Dayas, Associate Professor Ian Grainge, Jamie Quinton, Elizabeth Dinsdale, Prof Peter Cumpson, Jane Evans, Elizabeth Dinsdale, Jane Evans, Jamie Quinton
Scheme Linkage Infrastructure Equipment & Facilities (LIEF) Partner Funding
Role Investigator
Funding Start 2022
Funding Finish 2022
GNo G2201230
Type Of Funding Scheme excluded from IGS
Category EXCL
UON Y

BioSHeM: A High-Resolution Imaging and Spectroscopic Helium Atom Microscope$40,000

Funding body: University of New South Wales

Funding body University of New South Wales
Project Team Professor Paul Dastoor, Laureate Professor Roger Smith, Professor Alan Brichta, Professor Chris Dayas, Associate Professor Ian Grainge, Jamie Quinton, Elizabeth Dinsdale, Prof Peter Cumpson, Jane Evans, Elizabeth Dinsdale, Jane Evans, Jamie Quinton
Scheme Linkage Infrastructure Equipment & Facilities (LIEF) Partner Funding
Role Investigator
Funding Start 2022
Funding Finish 2022
GNo G2201231
Type Of Funding Scheme excluded from IGS
Category EXCL
UON Y

20211 grants / $108,934

Understanding the link between fatigue and impairments in motivation$108,934

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Chris Dayas, Doctor Lizzie Manning
Scheme Research Grant
Role Lead
Funding Start 2021
Funding Finish 2021
GNo G2101206
Type Of Funding C3300 – Aust Philanthropy
Category 3300
UON Y

20201 grants / $28,554

Research Funding for Treatment of alcohol dependence with an mTOR inhibitor (TAMI) Study$28,554

Funding body: Hunter New England Local Health District

Funding body Hunter New England Local Health District
Project Team Conjoint Professor Adrian Dunlop, Doctor Amanda Brown, Professor Chris Dayas, Doctor Madeleine Hinwood, Professor Jennifer Martin
Scheme Research Funding
Role Investigator
Funding Start 2020
Funding Finish 2023
GNo G2000584
Type Of Funding C2400 – Aust StateTerritoryLocal – Other
Category 2400
UON Y

20191 grants / $773,659

A novel pathways linking stress with mood disorders$773,659

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Chris Dayas, Professor Brett Graham
Scheme Project Grant
Role Lead
Funding Start 2019
Funding Finish 2021
GNo G1800444
Type Of Funding C1100 - Aust Competitive - NHMRC
Category 1100
UON Y

20184 grants / $2,081,525

Cognitive inflexibility and the development of pathological habits in brain diseases$897,715

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Chris Dayas, Professor Bernard Balleine, Dr Laura Corbit, Associate Professor Doug Smith, Professor Murray Cairns, Dr Billy Chieng, Professor Paul Kenny
Scheme Project Grant
Role Lead
Funding Start 2018
Funding Finish 2020
GNo G1700396
Type Of Funding C1100 - Aust Competitive - NHMRC
Category 1100
UON Y

Excitatory interneurons: a sensory amplifier for pathological pain $668,810

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Brett Graham, Conjoint Professor Robert Callister, Professor Chris Dayas, Dr David Hughes
Scheme Project Grant
Role Investigator
Funding Start 2018
Funding Finish 2020
GNo G1700334
Type Of Funding C1100 - Aust Competitive - NHMRC
Category 1100
UON Y

All-optical manipulation and recording of neural circuit activity$415,000

This project aims to establish all-optical approaches to image and manipulate neural function at single cell resolution in the awake, freely moving animal. The project will help build a 'cells to systems' understanding of neural circuit function and aid in understanding neural circuit dysregulation in brain disorders. This will enable new, fundamental knowledge creation about brain function, and lay a basic science platform for the next generation of understanding of brain disorders, critical to reducing their economic burden.

Funding body: ARC (Australian Research Council)

Funding body ARC (Australian Research Council)
Project Team

Professor Gavan McNally; Professor Bernard Balleine; Associate Professor Christopher Dayas; Professor Rick Richardson; Professor Andrew Killcross; Professor Alan Brichta; Associate Professor Brett Graham

Scheme Linkage Infrastructure Equipment & Facilities (LIEF)
Role Lead
Funding Start 2018
Funding Finish 2018
GNo
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON N

All-optical manipulation and recording of neural circuit activity$100,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Chris Dayas, Professor Alan Brichta, Professor Gavan McNally, Professor Brett Graham, McNully, Gavan
Scheme Equipment Grant
Role Lead
Funding Start 2018
Funding Finish 2018
GNo G1700451
Type Of Funding Internal
Category INTE
UON Y

20172 grants / $533,150

Hypothalamic Control Of Motivated Behavior$513,150

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Chris Dayas, Professor Brett Graham, Professor Gavan McNally, Dr Jaideep Bains
Scheme Project Grant
Role Lead
Funding Start 2017
Funding Finish 2019
GNo G1600298
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

A personality based intervention for treatment of addictive eating behaviours$20,000

Funding body: Society for Mental Health Research

Funding body Society for Mental Health Research
Project Team Professor Tracy Burrows, Dr Leanne Hides, Professor Chris Dayas, Professor Caroline Davis, Assistant Professor Ashley Gearhardt
Scheme Early Career Researcher Award
Role Investigator
Funding Start 2017
Funding Finish 2017
GNo G1700109
Type Of Funding C3200 – Aust Not-for Profit
Category 3200
UON Y

20162 grants / $540,121

Mechanisms underlying efferent feedback in the vestibular system$510,121

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Alan Brichta, Professor Brett Graham, Associate Professor Rebecca Lim, Conjoint Professor Robert Callister, Professor Chris Dayas, Dr Chris Holt, Professor Richard Rabbitt
Scheme Project Grant
Role Investigator
Funding Start 2016
Funding Finish 2019
GNo G1500239
Type Of Funding C1100 - Aust Competitive - NHMRC
Category 1100
UON Y

The Resilient Brain Initiative - Preclinical Neurobiology Group$30,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Chris Dayas, Professor Brett Graham
Scheme Project Grant
Role Lead
Funding Start 2016
Funding Finish 2016
GNo G1601532
Type Of Funding C3300 – Aust Philanthropy
Category 3300
UON Y

20153 grants / $280,000

Glencore-HMRI: Laser Applied Stimulation and Uncaging System$250,000

The LASU system is a dedicated microscope and electrophysiological rig for optogenetics.

Funding body: HMRI

Funding body HMRI
Scheme HMRI
Role Lead
Funding Start 2015
Funding Finish 2016
GNo
Type Of Funding Donation - Aust Non Government
Category 3AFD
UON N

How does stress increase vulnerability to food and drug addiction$20,000

Funding body: Coopers Brewery Foundation Inc Trust

Funding body Coopers Brewery Foundation Inc Trust
Project Team Professor Chris Dayas
Scheme Project Grant
Role Lead
Funding Start 2015
Funding Finish 2015
GNo G1501068
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

The involvement of the lateral hypothalamic orexin system in motivational behaviours$10,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Ms Erin Campbell, Professor Chris Dayas, Emeritus Professor Deborah Hodgson
Scheme Jennie Thomas Medical Research Travel Grant
Role Lead
Funding Start 2015
Funding Finish 2015
GNo G1401379
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

20141 grants / $25,000

Modulation of emotion by gut signals to the brain$25,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Chris Dayas
Scheme Project Grant
Role Lead
Funding Start 2014
Funding Finish 2014
GNo G1401518
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

20136 grants / $90,596

Ultra-Low Temperature Cryogenic Freezer$24,596

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Doctor Jude Weidenhofer, Doctor Rick Thorne, Associate Professor Kathryn Skelding, Associate Professor Nikki Verrills, Professor Pradeep Tanwar, Associate Professor Phillip Dickson, Professor Murray Cairns, Professor Hubert Hondermarck, Professor Xu Dong Zhang, Associate Professor Estelle Sontag, Doctor Chen Chen Jiang, Prof LIZ Milward, Doctor Jean-Marie Sontag, Associate Professor Paul Tooney, Doctor Severine Roselli Dayas, Professor Matt Dun, Professor Chris Dayas, Doctor Lin Kooi Ong, Professor Dirk Van Helden, Mr Ben Copeland, Doctor Gabrielle Briggs, Emeritus Professor Leonie Ashman, Emeritus Professor John Rostas
Scheme Equipment Grant
Role Investigator
Funding Start 2013
Funding Finish 2013
GNo G1201189
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

Identifying novel pharmacological targets for drug relapse$20,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Chris Dayas
Scheme Near Miss Grant
Role Lead
Funding Start 2013
Funding Finish 2013
GNo G1300473
Type Of Funding Internal
Category INTE
UON Y

Identifying novel pharmacological targets for drug relapse$20,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Chris Dayas
Scheme Near Miss
Role Lead
Funding Start 2013
Funding Finish 2013
GNo G1300827
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

Addictive drugs rewire the hypothalamus to drive relapse through brain 'reward' circuits$10,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Chris Dayas
Scheme Near Miss Grant
Role Lead
Funding Start 2013
Funding Finish 2013
GNo G1300474
Type Of Funding Internal
Category INTE
UON Y

Addictive drugs rewire the hypothalamus to drive relapse through brain 'reward' circuits$10,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Chris Dayas
Scheme Near Miss
Role Lead
Funding Start 2013
Funding Finish 2013
GNo G1300828
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

PhD Student Pulse Travel Award 'Dopamine 2013'$6,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Chris Dayas
Scheme Research Grant
Role Lead
Funding Start 2013
Funding Finish 2013
GNo G1300521
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

20124 grants / $53,211

Characterizing psychostimulant-induced synaptic plasticity in the hypothalamus$20,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Chris Dayas, Professor Brett Graham
Scheme Near Miss Grant
Role Lead
Funding Start 2012
Funding Finish 2012
GNo G1200677
Type Of Funding Internal
Category INTE
UON Y

Roles of post-transcriptional gene silencing in the functional regulation of neuronal gene expression and plasticity in schizophrenia$19,500

Funding body: Schizophrenia Research Institute

Funding body Schizophrenia Research Institute
Project Team Professor Murray Cairns, Ms Belinda Goldie, Professor Chris Dayas
Scheme Postgraduate Research Scholarship
Role Investigator
Funding Start 2012
Funding Finish 2014
GNo G1200761
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

Understanding the behavioural and neuroendocrine mechanisms of invasiveness in an avian system: do Indian mynahs display a dopaminergic-dependent invasion syndrome?$12,211

Funding body: University of Newcastle - Faculty of Science & IT

Funding body University of Newcastle - Faculty of Science & IT
Project Team Doctor Andrea Griffin, Professor Chris Dayas, Doctor David Guez
Scheme Strategic Small Grant
Role Investigator
Funding Start 2012
Funding Finish 2012
GNo G1401098
Type Of Funding Internal
Category INTE
UON Y

Addiction Research and Therapy, Embassy Suites Las Vegas, 20 - 22 August 2012$1,500

Funding body: University of Newcastle - Faculty of Health and Medicine

Funding body University of Newcastle - Faculty of Health and Medicine
Project Team Professor Chris Dayas
Scheme Travel Grant
Role Lead
Funding Start 2012
Funding Finish 2013
GNo G1200602
Type Of Funding Internal
Category INTE
UON Y

20112 grants / $35,000

Brain Mechanisms Conferring Psychostimulant Addiction$25,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Chris Dayas, Emeritus Professor Peter Dunkley, Associate Professor Doug Smith
Scheme Near Miss Grant
Role Lead
Funding Start 2011
Funding Finish 2011
GNo G1001052
Type Of Funding Internal
Category INTE
UON Y

IMPLEN NanoPhotometer pearl$10,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Murray Cairns, Associate Professor Paul Tooney, Professor Alan Brichta, Emeritus Professor John Rostas, Emeritus Professor Patricia Michie, Conjoint Professor Keith Jones, Prof ULLI Schall, Associate Professor Phillip Dickson, Professor Rohan Walker, Doctor Rick Thorne, Professor Chris Dayas, Associate Professor Nikki Verrills, Doctor Janet Bristow, Doctor Severine Roselli Dayas, Associate Professor Kathryn Skelding, Doctor Jude Weidenhofer, Prof LIZ Milward, Doctor Charles De Bock, Doctor Julie Merriman-Jones, Doctor Jing Qin Wu, Doctor Bing Liu, Doctor Dan Johnstone, Ms Belinda Goldie, Doctor Natalie Beveridge
Scheme Equipment Grant
Role Investigator
Funding Start 2011
Funding Finish 2011
GNo G1100030
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

20102 grants / $55,303

ABI 7500 Real Time PCR System $34,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Doctor Rick Thorne, Associate Professor Nikki Verrills, Professor Murray Cairns, Associate Professor Paul Tooney, Associate Professor Doug Smith, Professor Gordon Burns, Emeritus Professor Leonie Ashman, Conjoint Professor Keith Jones, Doctor Charles De Bock, Professor Chris Dayas, Professor Brett Graham, Doctor Martin Horan, Associate Professor Rebecca Lim, Doctor Severine Roselli Dayas, Doctor Larisa Bobrovskaya, Associate Professor Kathryn Skelding, Professor Rohan Walker, Doctor Jude Weidenhofer, Professor Philip Bolton, Professor Alan Brichta, Conjoint Professor Robert Callister, Professor Trevor Day, Associate Professor Phillip Dickson, Prof MANOHAR Garg, Associate Professor Phil Jobling, Professor Derek Laver, Associate Professor Eugene Nalivaiko, Emeritus Professor John Rostas
Scheme Equipment Grant
Role Investigator
Funding Start 2010
Funding Finish 2010
GNo G1000055
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

Characterising the synaptic physiology of orexin neurons in response to cocaine: Implications for drug relapse$21,303

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Chris Dayas, Professor Brett Graham
Scheme PULSE Early Career Researcher of the Year Award
Role Lead
Funding Start 2010
Funding Finish 2010
GNo G0900151
Type Of Funding Donation - Aust Non Government
Category 3AFD
UON Y

20081 grants / $398,978

Brain pathways underlying vulnerability to drug relapse$398,978

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Chris Dayas
Scheme Project Grant
Role Lead
Funding Start 2008
Funding Finish 2010
GNo G0187592
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

20074 grants / $57,500

Characterisation of the brain mechanisms linking vulnerability to stress and vulnerability to drug addiction$20,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Trevor Day, Professor Chris Dayas, Associate Professor Doug Smith
Scheme Project Grant
Role Investigator
Funding Start 2007
Funding Finish 2007
GNo G0187255
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

3D Imaging Software/Work station$20,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor David Pow, Professor Chris Dayas, Associate Professor Phil Jobling, Professor Derek Laver
Scheme Equipment Grant
Role Investigator
Funding Start 2007
Funding Finish 2007
GNo G0188026
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

Characterisation of the Brain Mechanisms linking vulnerability to stress and vulnerability to drug addiction$10,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Chris Dayas
Scheme Early Career Researcher Grant
Role Lead
Funding Start 2007
Funding Finish 2007
GNo G0187312
Type Of Funding Internal
Category INTE
UON Y

Molecular and cellular mechanisms underpinning drug relapse$7,500

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Chris Dayas
Scheme New Staff Grant
Role Lead
Funding Start 2007
Funding Finish 2007
GNo G0187726
Type Of Funding Internal
Category INTE
UON Y

20061 grants / $134,500

Neural links between drug addiction and stress$134,500

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Chris Dayas, Professor Trevor Day
Scheme Training (Postdoctoral) Fellowships - C.J. Martin Biomedical Fellowships (Overseas)
Role Lead
Funding Start 2006
Funding Finish 2008
GNo G0187071
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y
Edit

Research Supervision

Number of supervisions

Completed17
Current4

Current Supervision

Commenced Level of Study Research Title Program Supervisor Type
2023 PhD Investigating Interactions Between Stress and Action-Control Pathways Associated with Repetitive Behaviours in OCD and Tourette Syndrome PhD (Human Physiology), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2023 PhD Resetting Hypothalamic circuits to Treat Depression PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2022 PhD How does Stress Impact Striatal Circuits involved in Behavioural Dysfunction Relevant to Stress-Related Neuropsychiatric Disorders PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2019 PhD Exploring Causal Architecture of Schizophrenia and Alzheimer's Disease to Identify New Drug Targets PhD (Medical Genetics), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor

Past Supervision

Year Level of Study Research Title Program Supervisor Type
2024 PhD Investigating the Role of Striatal Direct and Indirect Pathway Spiny Projection Neurons in a Cocaine-Induced Impairment of Goal-Directed Behavioural Control PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2024 PhD Shining Light on the Contribution of Spinal Projection Neurons to the Local Spinal Cord and Wider Nervous System PhD (Human Physiology), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2023 PhD Using Chemical and Light Activation of Neurons to Study Pain Mechanisms and Screen Analgesic Compounds PhD (Human Physiology), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2023 PhD Procedures for Manipulating the Speed-Accuracy Trade-Off PhD (Psychology - Science), College of Engineering, Science and Environment, The University of Newcastle Co-Supervisor
2023 PhD Exploration of the Molecular Determinants of Comorbid Addiction in Schizophrenia PhD (Medical Genetics), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2022 PhD How do Medial Amygdala (MeA) Excitatory Neurons Control Behavioural Responses to Olfactory Stimuli? PhD (Medical Genetics), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2022 PhD Understanding the Impact of Addictive Drugs on Stress Circuits PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2020 PhD Characterising how Chronic Stress and Natural Rewards Impact Lateral Hypothalamic Circuitry PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2020 PhD Investigating Objective Biomarkers to Characterise Addictive Eating PhD (Nutrition & Dietetics), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2018 PhD Channelrhodopsin-Assisted Circuit Mapping of Medial Amygdaloid Connectivity to the Paraventricular Nucleus of the Hypothalamus PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2016 PhD Ageing of the Somatic Motor Nervous System: A Nuclear and Mitochondrial Genome Perspective PhD (Medical Biochemistry), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2016 PhD Understanding Striatal Neuroadaptations in Addiction-Relapse Vulnerability PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2016 PhD Characterizing Changes in the Orexin System in Models of Neuropsychiatric Disease PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2015 PhD Drug-induced Changes to the Lateral Hypothalamic Circuits and Downstream Projection Targets PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2015 PhD Roles of Post-Transcriptional Gene Silencing in the Functional Regulation of Neuronal Gene Expression and Plasticity PhD (Medical Biochemistry), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2014 PhD The Role of Cocaine- and Amphetamine-Regulated Transcript (CART) and Orexin in Drug-Seeking and Addiction-Related Behaviours PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
2012 PhD Molecular Correlates of Dopamine Signalling in Addiction Vulnerability PhD (Anatomy), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
Edit

Research Collaborations

The map is a representation of a researchers co-authorship with collaborators across the globe. The map displays the number of publications against a country, where there is at least one co-author based in that country. Data is sourced from the University of Newcastle research publication management system (NURO) and may not fully represent the authors complete body of work.

Country Count of Publications
Australia 68
United States 24
United Kingdom 9
Canada 7
Japan 2
More...
Edit

News

Spinal cord research

News • 15 Dec 2022

Spinal cord pain to PTSD: $5.2m in NHMRC grants to target pressing medical conditions

Both the body and the mind will be a key focus for innovative researchers from the University of Newcastle, who were successful in the latest round of National Health and Medical Research Council (NHMRC) Ideas Grants.

NHMRC 2018 Project grants

News • 12 Dec 2018

NHMRC awards $12.4 million to 14 Newcastle projects

The National Health and Medical Research Council (NHMRC) has awarded the University of Newcastle more than $12.4 million to support 14 projects that are aiming to solve some of the world’s most critical health problems and improve the lives of millions of Australians.

News • 18 Apr 2018

Food addiction: why your mind matters

A world-first, personality-based online intervention for food addiction is being developed by a team* of dietitians, psychologists, neuroscientists, occupational therapists and health researchers.

microscope

News • 30 Apr 2015

Microscope to shed light on mental health

A laser-equipped microscope that gives brain researchers unparalleled insight into mental illness has just been installed at the University of Newcastle.

Professor Chris Dayas

Position

Assistant Dean Research
School of Biomedical Sciences and Pharmacy
College of Health, Medicine and Wellbeing

Focus area

Anatomy

Contact Details

Email christopher.dayas@newcastle.edu.au
Phone (02) 4921 5618
Fax (02) 4921 7904
Link UoN Blogs

Office

Room MS612
Building Medical Sciences
Location Callaghan
University Drive
Callaghan, NSW 2308
Australia
Edit